For the fiscal year ending March 2027, consolidated full-year earnings guidance has been revised to net sales of 167,980 hundred million yen, operating income of 10,286 million yen, ordinary income of 10,716 million yen, net income attributable to owners of parent of 6,866 million yen, and earnings per share of 222.25 yen. The revision reflects stronger-than-expected unit prices for dispensing fees and technical fees in the pharmacy business since the interim period, efficiency gains in the silver business, and the consolidation of QLC Produce. The consolidated operating income target of 9.5 hundred million yen in the medium-term plan is expected to be achieved one year ahead of schedule. Annual dividend is raised to 89 yen, with a year-end dividend of 49 yen (interim 40 yen, year-end 49 yen, annual 89 yen).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"9729","jir_company_name":"TOKAI Corp.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-22","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/9729-20261022-01.pdf","jir_short_summary":"For the fiscal year ending March 2027, consolidated full-year earnings guidance has been revised to net sales of 167,980 hundred million yen, operating income of 10,286 million yen, ordinary income of 10,716 million yen, net income attributable to owners of parent of 6,866 million yen, and earnings per share of 222.25 yen. The revision reflects stronger-than-expected unit prices for dispensing fees and technical fees in the pharmacy business since the interim period, efficiency gains in the silver business, and the consolidation of QLC Produce. The consolidated operating income target of 9.5 hundred million yen in the medium-term plan is expected to be achieved one year ahead of schedule. Annual dividend is raised to 89 yen, with a year-end dividend of 49 yen (interim 40 yen, year-end 49 yen, annual 89 yen).","jir_summary":"### Summary of Earnings Revision\nFull-year net sales and all profit indicators are expected to exceed the previous guidance, supported by higher-than-expected unit prices for dispensing fees and technical fees in the pharmacy business and efficiency gains in rental materials. The performance of QLC Produce, which has been grouped into the group, is now reflected on a consolidated basis and is expected to contribute to profit from its initial period. The consolidated operating income target of 9.5 hundred million yen, originally scheduled for the final year of the medium-term plan (fiscal year ending March 2028), is expected to be achieved one year earlier.\n\n### Dividend Policy and Shareholder Returns\nThe annual dividend is revised to 89 yen (interim 40 yen, year-end 49 yen, total 89 yen) while maintaining the progressive dividend policy. The interim dividend will be submitted to the November board meeting and the year-end dividend to the June general meeting of shareholders. The company continues to prioritize shareholder returns and will strengthen returns in consideration of target payout ratios.","jir_financial_highlights":"Net Sales: 167,980 hundred million yen (Previous guidance 165,400 hundred million yen \u2192 Revised guidance 167,980 hundred million yen (increase))\nOperating Income: 10,286 million yen (Previous guidance 8,985 million yen \u2192 Revised guidance 10,286 million yen (increase))\nOrdinary Income: 10,716 million yen (Previous guidance 9,437 million yen \u2192 Revised guidance 10,716 million yen (increase))\nNet Income Attributable to Owners of Parent: 6,866 million yen (Previous guidance 6,117 million yen \u2192 Revised guidance 6,866 million yen (increase))\nEarnings Per Share: 222.25 yen (Previous guidance 198.08 yen \u2192 Revised guidance 222.25 yen (increase))","jir_category":"","jir_hashtags":"#NoSpecificInternalIRTagForTOKAI","jir_key_figures":"Net Sales: 167,980 hundred million yen (increase of 2,580 hundred million yen from previous guidance)\nOperating Income: 10,286 million yen (increase of 1,301 million yen from previous guidance)\nNet Income Attributable to Owners of Parent: 6,866 million yen (increase of 748 million yen from previous guidance)","jir_meta_title":"TOKAI Corp. \u2013 Revision of Earnings Guidance and Dividend Forecast | October 22, 2026","jir_meta_description":"TOKAI Corp. revises its consolidated earnings guidance for the fiscal year ending March 2027 and updates its dividend forecast. Net sales of 167,980 hundred million yen, operating income of 10,286 million yen, and year-end dividend raised to 49 yen are announced, along with progress on the medium-term plan.","jir_og_title":"TOKAI Corp. Revision of Earnings Guidance and Dividend Forecast","jir_og_description":"TOKAI Corp. raises its earnings guidance for the fiscal year ending March 2027 and increases dividends. The announcement explains factors behind stronger performance and accelerated achievement of the medium-term plan.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":16786,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-133299","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n